← Back to Search

eScreening for Mental Health in Veterans

N/A
Waitlist Available
Led By James Pittman, PhD MSW
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (6-18months), post (18-27months), and followup (27-36months).
Awards & highlights
No Placebo-Only Group

Summary

This trial will investigate whether electronic screening is more effective than usual screening for detecting suicidal ideation and other mental health symptoms in Veterans.

Who is the study for?
This trial is for VA staff involved in implementing eScreening, a system to detect mental health issues like depression and PTSD in Veterans. Participants must be able to give informed consent and play a role in the eScreening process at their site.
What is being tested?
The study tests how well eScreening works compared to usual screening methods for identifying mental health symptoms among Veterans. It also examines the effectiveness of a multi-component strategy for rolling out eScreening across VA Transition Care Management clinics.
What are the potential side effects?
Since this trial involves an electronic screening tool rather than medication, traditional side effects are not applicable. However, there may be indirect effects on workflow or data management that will be monitored.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (6-18months), post (18-27months), and followup (27-36months).
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (6-18months), post (18-27months), and followup (27-36months). for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in rate of screening completion
Change in time to screening completion
Secondary study objectives
Change in rate of referral to care

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Stepped-wedgeExperimental Treatment2 Interventions
This stepped-wedge trial relies on sequential roll-out of eScreening to participating sites over time, while using other sites as controls until they begin implementation.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,664 Previous Clinical Trials
3,765,597 Total Patients Enrolled
78 Trials studying Depression
19,909 Patients Enrolled for Depression
James Pittman, PhD MSWPrincipal InvestigatorVA San Diego Healthcare System, San Diego, CA

Media Library

Stepped-wedge Clinical Trial Eligibility Overview. Trial Name: NCT04506164 — N/A
Depression Research Study Groups: Stepped-wedge
Depression Clinical Trial 2023: Stepped-wedge Highlights & Side Effects. Trial Name: NCT04506164 — N/A
Stepped-wedge 2023 Treatment Timeline for Medical Study. Trial Name: NCT04506164 — N/A
~15 spots leftby Dec 2025